comparemela.com

Latest Breaking News On - Regen biopharma - Page 17 : comparemela.com

CERTAIN FORWARD-LOOKING INFORMATION Information provided in this Quarterly report on Form 10Q may contain forward-looking statements within the meaning of Section 21E or Securities Exchange Act of. | January 20, 2022

United statesExchange commissionRegen biopharma incOncology pharma incZander therapeutics incSecurities exchangeSecurities exchange actQuarterly reportAccounts receivablePrepaid expensesRelated partyOncology pharmaAccounts payableCalifornia codeCivil procedureAccrued interest payable

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regen BioPharma, Inc

/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Regen BioPharma, Inc. ("Regen" or the "Company") (OTCMKTS: RGBP). Such.

New yorkUnited statesFrance generalTel avivLos angelesAbrahaml pomerantzRoberts willoughbyExchange commissionCompany formRegen biopharma incPrnewswire pomerantzCompany board of directorsRegen biopharmaBalance sheetShareholders equityCash flow

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regen BioPharma, Inc

/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Regen BioPharma, Inc. ("Regen" or the "Company") (OTCMKTS: RGBP). Such.

New yorkUnited statesFrance generalTel avivLos angelesAbrahaml pomerantzRoberts willoughbyExchange commissionCompany formRegen biopharma incPrnewswire pomerantzCompany board of directorsRegen biopharmaBalance sheetShareholders equityCash flow

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regen BioPharma, Inc

/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Regen BioPharma, Inc. ("Regen" or the "Company") (OTCMKTS: RGBP). Such.

New yorkUnited statesFrance generalTel avivLos angelesAbrahaml pomerantzRoberts willoughbyExchange commissionCompany formRegen biopharma incPrnewswire pomerantzCompany board of directorsRegen biopharmaBalance sheetShareholders equityCash flow

REGEN BIOPHARMA, INC : MESSAGE TO THE SHAREHOLDERS FROM THE CHAIRMAN AND CHIEF EXECUTIVE OFFICER

/PRNewswire/ Regen BioPharma, Inc. (PINK: RGBP) and (PINK: RGBPP): First of all I would like to wish all our shareholders a happy holiday season. It has.

United statesRegen biopharmaDavidr koosRegen biopharma incPrnewswire regen biopharma incTrademark officeOncology pharma incContract researchChemdiv our contract researchUnited states patentOncology pharmaNet salesLicensed productsAccounting standard codificationFinancial accounting standards board

vimarsana © 2020. All Rights Reserved.